Last updated on March 2018

Radial Extracorporeal Shock Wave Therapy for Acute Hamstring Muscle Complex Injury Type 3b in Athletes


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: sports injury
  • Age: Between 18 - 35 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Adults (both male and female) with clinical and ultrasonographic diagnosis of acute HMC injury Type 3b
  • Age range: between 18 and 35 years
  • Physical conditions for rehabilitation (i.e., no surgery required)
  • Willingness of the patient to participate in the study, and written informed consent signed and personally dated by the patient
  • No contraindications for rESWT

Exclusion Criteria:

  • Children and teenagers below the age of 18
  • Adults aged >35 years old
  • Patients with clinical and ultrasonographic diagnosis of acute HMC injury Type 3b who got injured more than seven days before potential enrollment into this study
  • Patients with clinical and ultrasonographic diagnosis of acute HMC injury Type 3A or Type 4
  • Bilateral acute HMC injury (Types 3A, 3B or 4)
  • Proven or suspected HMC injury (Types 3A, 3B or 4) of the same lower limb in the time period of six months before potential enrollment into this study
  • Muscle injury caused by external impact on the back of the affected thigh
  • Surgery on the affected lower limb in the time period of one year before potential enrollment into this study
  • Acute or chronic lumbar pathology (because some cases of thigh pain may relate to spinal pathology)
  • No willingness of the patient to participate in this study, and/or written informed consent not signed and not personally dated by the patient
  • Contraindications of rESWT, i.e., treatment of pregnant patients, treatment of patients with blood-clotting disorders (including local thrombosis), treatment of patients treated with oral anticoagulants, treatment of patients with local bacterial and/or viral infections/inflammations, treatment of patients with local tumors, and treatment of patients treated with local corticosteroid applications in the time period of six weeks before the first rESWT session (if applicable).

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.